All diabetes articles – Page 3
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
- Previous Page
- Page1
- Page2
- Page3
- Next Page
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands